1-3 of 3
Howard Weiner
Close
Sort by
Journal Articles

Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy

Clinical Trials & Observations
Anand Ashwin Patel, Alexandra E. Rojek, Michael W. Drazer, Howard Weiner, Lucy A. Godley, Michelle M. Le Beau, Richard A. Larson
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4140–4148.
https://doi.org/10.1182/bloodadvances.2021004964
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia

Clinical Trials & Observations
Kirk E. Cahill, Yasmin H. Karimi, Theodore G. Karrison, Nitin Jain, Margaret Green, Howard Weiner, Noreen Fulton, Sabah Kadri, Lucy A. Godley, Andrew S. Artz, Hongtao Liu, Michael J. Thirman, Michelle M. Le Beau, Megan E. McNerney, Jeremy Segal, Richard A. Larson, Wendy Stock, Olatoyosi Odenike
Journal: Blood Advances
Blood Adv (2020) 4 (4): 599–606.
https://doi.org/10.1182/bloodadvances.2019000795
Published: 2020
Includes: Supplemental data
Journal Articles

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL

Clinical Trials & Observations
Sabah Kadri, Jimmy Lee, Carrie Fitzpatrick, Natalie Galanina, Madina Sukhanova, Girish Venkataraman, Shruti Sharma, Brad Long, Kristin Petras, Megan Theissen, Mei Ming, Yuri Kobzev, Wenjun Kang, Ailin Guo, Weige Wang, Nifang Niu, Howard Weiner, Michael Thirman, Wendy Stock, Sonali M. Smith, Chadi Nabhan, Jeremy P. Segal, Pin Lu, Y. Lynn Wang
Journal: Blood Advances
Blood Adv (2017) 1 (12): 715–727.
https://doi.org/10.1182/bloodadvances.2016003632
Published: 2017
Includes: Supplemental data